Why the study?
The study aimed to investigate fatty acids, lipid mediator levels, and desaturase index rates across different acute coronary syndrome types and assess their relationship with routine lipid parameters.
Do fatty acids and lipid mediator levels differ between patients with acute coronary syndrome and healthy controls?
Do fatty acids and lipid mediator levels differ between patients with acute coronary syndrome and healthy controls?
Lipid mediators and fatty acid ratios differ significantly between patients with myocardial infarction and healthy controls, suggesting a potential role in evaluating atherosclerosis and inflammation.
OBJECTIVE: The aim of this study was to investigate fatty acids, lipid mediator levels, and the desaturase index rates on different acute coronary syndrome types and their possible relationship with routine lipid parameters. METHODS: The study included 81 patients with myocardial infarction (MI), 20 patients with unstable angina pectoris, and 31 healthy people. Fatty acids, CD59, lipoxin A4, 8-isoprostane, serum lipids, albumin, C-reactive protein (CRP), and high sensitive troponin levels were measured in all participants. RESULTS: When the fatty acid groups were evaluated as a ratio of albumin, MUFA/albumin and SFA/albumin ratios were significantly higher in the MI group compared to the control group. Although CD59 and lipoxin A4 levels were higher in the control group, there was no significant differences between the groups. When lipoxin A4/CRP and CD59/CRP ratios were evaluated, the results were significantly lower than those in the control group. CONCLUSION: Lipid mediators may be useful in treating atherosclerosis by contributing to the resolution of inflammation.
No takes yet. Share an insight, caveat, or question.
Ünal et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: